Tak 242 cli 095
TAK-242 (CLI-095) is a small molecule inhibitor that selectively targets Toll-like receptor 4 (TLR4). It acts by blocking the intracellular signaling of TLR4, which is involved in the activation of inflammatory responses.
Lab products found in correlation
6 protocols using tak 242 cli 095
Preparation of DOPC Lipid Nanoparticles
Lipid and Inflammatory Mediator Assays
LPS-induced Inflammatory Responses
Modulating Inflammatory Pathways in Cells
Modulation of Inflammatory Pathways
Regulation of SAA-induced inflammation
Substances: recombinant human SAA (rhSAA, contains SAA1 and SAA2, Peprotech, Hamburg, Germany), LPS (Sigma-Aldrich, Munich, Germany), HKSA (InvivoGen, Toulouse, France), Bz-ATP (Sigma-Aldrich, Munich, Germany), OxPAPC (InvivoGen, Toulouse, France), KN-62 (Sigma-Aldrich, Munich, Germany), CLI-095 (TAK-242, InvivoGen, Toulouse, France), Bay11-7082 (Calbiochem, MerckMillipore, Darmstadt, Germany).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!